Source comparison
Quick Comparison: GH Secretagogues and Related Compounds
Compound Category Main Pathway Peptide? Key Research Distinction CJC-1295 with DAC GHRH analog GHRH receptor Yes Long-acting GH-axis signaling via DAC/albumin binding CJC-1295 No DAC / Modified GRF (1-29 Shorter, pulse-like GHRH signaling Sermorelin Classic GH
This comparison does not assign a generated winner or score.
- Compound
- Category
- Main Pathway
- Peptide?
- Key Research Distinction
- CJC-1295 with DAC
- GHRH analog
- GHRH receptor
- Yes
- Long-acting GH-axis signaling via DAC/albumin binding
- CJC-1295 No DAC / Modified GRF (1-29
- Shorter, pulse-like GHRH signaling
- Sermorelin
- Classic GHRH(1-29) analog
- Tesamorelin
- FDA-approved in a specific HIV-associated lipodystrophy context
- Ipamorelin
- GHRP / ghrelin mimetic
- GHSR-1a
- Selective GH secretagogue studied for GH release with limited ACTH/cortisol activity
- GHRP-2
- GHRP
- Potent older GH secretagogue peptide
- GHRP-6
- Older GHRP often associated with appetite/ghrelin-like signaling
- Hexarelin
- GHSR-1a and related pathways
- Potent GHRP with GH and cardiac research interest
- MK-677 / Ibutamoren
- Non-peptide secretagogue
- No
- Oral ghrelin mimetic; not a peptide
- HGH / GH
- Hormone
- GH receptor
- Not a secretagogue; bypasses upstream GH release pathways